Ø Boosting India’s plan to enhance strategic
deterrence capability, the first long-range sub-sonic cruise missile, Nirbhay, was test-fired for a range
of over 1,000 km from the Integrated Test Range. The success came in the second
flight trial as the first had to be terminated midway in March last year after
it deviated from the pre-designated trajectory. The tree-top, low-altitude
flying missile, which can evade radars, was fired from a canister-based mobile
launcher from Launch Complex-3 here at 10.05 a.m. After it took off vertically
like a rocket, the first-stage rocket booster got jettisoned within seconds at
an altitude of 100 metres and the wings got deployed as the missile tilted
horizontally.
Nirbhay Cruise Missile |
Ø The U.S.-based National Institutes of Health
(NIH) will fund a study on providing better care for people suffering from
diabetes and depression in India. The study will be carried out by the Madras
Diabetes Research Foundation (MDRF), Chennai; the All India Institute of
Medical Sciences; New Delhi; and the Endocrine and Diabetes Centre,
Visakhapatnam. University of Washington Seattle and Emory University will be
the partner institutions in the U.S.
Ø Taking former Tamil Nadu Chief Minister
Jayalalithaa on her word that there will be no attempt to delay criminal appeal
proceedings in the Karnataka High Court, the Supreme Court suspended her
four-year sentence in the disproportionate assets case and granted her bail.
No comments:
Post a Comment